Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05225584
Title Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kymera Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC Irvine Health-Chao Family Comprehensive Cancer Center Orange California 92868-3201 United States Details
Norton Cancer Institute Louisville Kentucky 40207 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Hackensack University Medical Center, John Theurer Cancer Center Hackensack New Jersey 07601 United States Details
Montefiore Medical Center, The University Hospital for Albert Einstein College of Medicine Bronx New York 10467 United States Details
The Christ Hospital Cancer Center Cincinnati Ohio 45219 United States Details
Ohio State University Wexner Medical Center Columbus Ohio 43210-1240 United States Details
Abramson Cancer Center of the University of Pennsylvania Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104 United States Details
Thomas Jefferson University, Sidney Kimmel Cancer Center Philadelphia Pennsylvania 19107 United States Details
Rhode Island Hospital Providence Rhode Island 02903 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Virginia, Emily Couric Cancer Center Charlottesville Virginia 22903 United States Details
University of WA/Seattle Cancer Care Alliance Seattle Washington 98195 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field